NCT01607489 Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography Status COMPLETED Phase NA
NCT01600898 Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers Status COMPLETED Phase N/A
NCT01582438 An Open Label Access Study For Subjects Who Completed A1481156 Status NO_LONGER_AVAILABLE Phase N/A
NCT01572077 Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT01560637 An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT01560624 Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Status COMPLETED Phase PHASE3
NCT01557647 Safety and Efficacy of Inhaled Treprostinil in Patients With PAH Status WITHDRAWN Phase PHASE3
NCT01553721 Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) Status COMPLETED Phase PHASE2
NCT01548950 Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension Status COMPLETED Phase NA
NCT01545336 Anastrozole in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT01520493 Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT01508780 Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan Status WITHDRAWN Phase PHASE4
NCT01496963 Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia Status COMPLETED Phase N/A
NCT01494896 Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching Status TERMINATED Phase N/A
NCT01484431 A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT01477333 Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® Status COMPLETED Phase PHASE2
NCT01470144 Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3